Weight Loss.

Cagrilintide is a synthetic long-acting amylin analogue developed for experimental investigation of amylin receptor–mediated signalling and peptide hormone interactions involved in metabolic regulation pathways.

Sequence / formula: N/A - not a peptide; no amino acid sequence.

Not a single peptide: Lipo-C is a lipotropic injection/blend product with formulation-dependent non-peptide ingredients.

MOTS-c is a specialised mitochondrial-derived peptide (MDP) developed for advanced scientific exploration of metabolic regulation, mitochondrial signalling, and cellular stress-response pathways, commonly studied in models of insulin sensitivity, energy homeostasis, and adaptive metabolism.

Retatrutide (LY3437943) is an investigational triple GIP/GLP-1/glucagon receptor agonist peptide supplied for laboratory research into multi-receptor incretin signalling and metabolic regulation in experimental systems.

Semaglutide is a synthetic GLP-1 receptor agonist peptide supplied for laboratory research into incretin signalling, glucose regulation and appetite-related pathways in experimental systems.

SLU-PP-332 is an experimental compound often referred to as "exercise in a pill". It is a synthetic agonist that targets estrogen-related receptors (ERRs) to artificially stimulate metabolic gene programs, mimicking the fat-burning and endurance-boosting effects of intense aerobic exercise. [1, 2]

Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist peptide supplied for laboratory research into incretin receptor signalling, glucose homeostasis and energy-balance pathways in experimental systems.